Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N02 ANALGESICS
N02B OTHER ANALGESICS AND ANTIPYRETICS
N02BF Gabapentinoids
N02BF01 Gabapentin
D00332 Gabapentin (JAN/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Anticonvulsants
Gamma-aminobutyric Acid (GABA) Augmenting Agents
GABA Agents, Other
Gabapentin
D00332 Gabapentin (JAN/USP/INN)
Central Nervous System Agents
Central Nervous System, Other
Gabapentin
D00332 Gabapentin (JAN/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
1 Agents affecting nervous system and sensory organs
11 Agents affecting central nervous system
113 Antiepileptics
1139 Others
D00332 Gabapentin (JAN/USP/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG03199 Antiepileptic agent
DG02037 GABA mimetic antiepileptic
DG01574 Calcium channel alpha-2 delta blocker
DG01245 Gabapentin
D00332 Gabapentin
Drug classes [BR:br08332]
Neuropsychiatric agent
DG03199 Antiepileptic agent
D00332 Gabapentin
Target-based classification of drugs [BR:br08310]
Ion channels
Voltage-gated ion channels
Calcium channels
CACNA2D
D00332 Gabapentin (JAN/USP/INN) <JP/US>
Transporters
Solute carrier family
SLC6
SLC6A1 (GAT1)
D00332 Gabapentin (JAN/USP/INN) <JP/US>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D00332
Prodrugs [br08324.html]
D00332
Prodrugs [br08324.html]
C07018
